Neurogene
NGNE
NGNE
22 hedge funds and large institutions have $27.6M invested in Neurogene in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$558K | |
| 2 | +$133K | |
| 3 | +$107K | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$49.6K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$20K |
Top Sellers
| 1 | -$1.78M | |
| 2 | -$680K | |
| 3 | -$451K | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$72K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$33.3K |